Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.31949 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.58255 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.25249 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.42113 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.17019 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.52789 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.57137 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.28655 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.23988 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.15485 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.26686 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.14741 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.2718 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.25842 | 69 |